Funding for TB research and development declining
Interruption of TB treatment due to drug supply problems common in UK
Private sector TB treatment in Asia: a lot of it, but often sub-optimal
Vigilance needed over MDR-TB in children, South African doctors warn
Managing MDR-TB in the community: from presentation to cure or end-of-life care
Decentralised, patient-centred models of delivering treatment and palliative care for people with M/XDR-TB
Towards more compassionate and effective care for drug resistant TB: improving diagnosis and case detection
Patients taking TB treatment may be potentially infectious for longer than previously thought
Towards more compassionate care for people with drug-resistant TB
